Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

Class IA PI3K Inhibitor Cancer Therapies
August 16, 2016

Class IA PI3K Inhibitor Cancer Therapies

Date: August 16, 2016 Author: Andrea Tarbet, Product Marketing Associate at ALPCO Bruton’s tyrosine kinase (BTK) inhibitors are not the only kinase inhibitors to enter the fight against B cell cancers. Since there are numerous subtypes of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), patients around the world are in need of diverse treatments and cures. As a result, different type...
Customer Spotlight: Measuring Functionality Islet Microtissues
July 26, 2016

Customer Spotlight: Measuring Functionality of Islet Microtissues

Date: July 26, 2016 Beta cell generation has gained much traction in recent years among diabetes researchers. Investigators are not only converting adipose tissue and skin cells into beta cells, they are also starting to grow beta cells in a petri dish in vitro. Swiss company InSphero has begun measuring functionality of islet microtissues through the use of STELLUX® Chemiluminescent assays....
BTK Inhibitors as Cancer Drug Treatments
July 26, 2016

BTK Inhibitors as Cancer Drug Treatments

Date: July 26, 2016 Author: Andrea Tarbet, Product Marketing Associate at ALPCO Over the past several years, the drug arsenal to combat B cell cancers has gained a mighty weapon: Bruton’s tyrosine kinase (BTK) inhibitors. The origins of using BTK inhibitors as cancer drug treatments actually began with researching drug treatments for an autoimmune disease. Two decades later, the first BTK...
De-escalating Irritable Bowel Disease Therapies
June 21, 2016

De-escalating Inflammatory Bowel Disease Therapies

Date: June 21, 2016 Author: Andrea Tarbet, Product Marketing Associate at ALPCO Several therapies exist to help treat inflammatory bowel disease (IBD) and improve patient quality of life. However, a growing number of gastroenterologists and patients have been choosing to stop these therapies - a process known as de-escalation. There is currently no standard of care for de-escalating infla...
Changing Roles of Bone Remodeling Biomarkers
June 8, 2016

The Changing Roles of Bone Remodeling Biomarkers

Introduction Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes of mineral balance and blood cell production. Research supports that bones do more than they were originally recognized for. Previous research investigating osteocalcin not only helped to change the scientific community’s understanding of bones, but also incr...
ALPCO Releases a New Broad Range Periostin ELISA
June 7, 2016

ALPCO Releases a New Broad Range Periostin ELISA

ALPCO is now offering a new broad range Periostin ELISA that has been optimized to detect all known splicing forms of human periostin. The Periostin ELISA is highly characterized with a full validation package, and offers great reproducibility and precision. Not only are all standards and controls included with the kit, but it can be automated, making the assay both cost effective and flexible ...
The Significance of Bioactive Leptin in Obesity Research
May 3, 2016

The Significance of Bioactive Leptin in Obesity Research

May 3, 2016 Leptin resistance is a challenging topic of conversation in obesity. It is defined by a state in which the body does not display any adapted response to high endogenous or exogenous levels of leptin while continuing to maintain excess body weight1. This may be due to a decreased uptake of leptin in the brain, reduced central response to leptin, or hypothalamic inflammation1. Cong...
Investigating Bioactive Leptin in Obesity Research
April 26, 2016

Investigating Bioactive Leptin in Obesity Research

The Biology of Leptin Leptin is a hormone composed of 167 amino acids and is primarily produced by adipocytes, therefore providing a signal to the energy state of organisms. By binding to the leptin receptor, the analyte influences activity within the JAK-STAT pathway and thereby regulates energy metabolism and food intake in particular1,2. Leptin levels show a circadian variation (+/- 30%) an...
Early Detection Diabetic Kidney Disease
April 12, 2016

Early Detection of Diabetic Kidney Disease with Biomarkers

Introduction Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of diabetics suffering from DKD, current methods for measuring and tracking kidney function may not be specific enough for diabetic systems2,3. Part III of The Common Denominator eBook series examines the kidney complications caused by diabetes, and current resear...
How Runners' High and Leptin Play a Role in Metabolism
April 6, 2016

How Runners' High and Leptin Play a Role in Metabolism

  As a runner, I’ve long been intrigued by what gets me high during my runs. Endorphins, you say? Yes, I’m well aware of those and bless those endorphins. But, I have to say, there’s nothing quite as satiating as a good run and as a scientist by training, I was convinced that there was more to that feeling than endorphins. Turns out, there is. It wasn’t too long ago that I came acros...